BLUF
Semaglutide—a drug commonly used for weight-loss—also slows kidney disease in type 2 diabetics, improving function and survival. Benefits likely stem from metabolic effects, though exact mechanisms need further research.Learning Outcomes
- Explain how semaglutide works to manage type 2 diabetes and support weight loss.
- Evaluate evidence showing semaglutide improves kidney function, survival, and cardiovascular outcomes.
- Discuss the interconnected roles of obesity, diabetes, and kidney disease.
